The First
Cognitive Vital Sign
Subtle sensory shifts appear long before symptoms are obvious
Developed with researchers from Columbia, Johns Hopkins, Harvard, and beyond.
Validation Evidence
The first longitudinal dataset built from repeatable, self-administered testing across all five senses, establishing a new reference standard for early functional decline.
Population patterns
Consistent with Large-Scale Population Studies
Mortality risk rises with severity of sensory changes.Hearing and vision impairments show clear dose-dependent hazard ratios.
Functional decline modeled with and without early sensory intervention.Tracking senses defines the window where slope can still be changed.
Measured prevalence of reduced sensory function in our cohort matches rates reported in large-scale studies (NIH, JAMA, Lancet).
Expected age-related decline contrasted with trajectories shaped by cumulative life events.
This moves large-scale patterns into a personal, trackable framework.
Individual Sensory Tests
Distribution of function across each sense in our cohort.
Variability is measurable and consistent with population biology
Scientific Leadership
SuperSenses' Chief Medical Officer
Dr. Vince Bennett 's commitment to advancing healthcare made him the Principal Investigator for the landmark UCLA FAST-MAG study. Today, his focus is on longevity medicine, specializing in exosomes and stem cells, where he’s developing protocols for both elite athletes and geriatric patients. Dr. Bennett’s passion for preventive healthcare, such as SuperSenses, aligns with his belief in the power of early interventions, which led him to join our team enthusiastically.
Sita Kedia, MD, MPH
Preventive Neurology & Brain Health
Dr. Kedia is a triple board-certified neurologist and brain health specialist focused on early, preventive approaches to cognitive change. She works at the intersection of clinical neurology and lifestyle medicine, helping people translate complex neuroscience into everyday decisions.
"Early changes in smell and hearing are often the brain’s first quiet signals that something is shifting. We should be tracking those senses as routinely as blood pressure or cholesterol—and tools like SuperSenses finally make that kind of at-home tracking realistic, so we can pay attention to changes long before more obvious symptoms appear.”
Reza Hosseini Ghomi, MD, MSE
Neuropsychiatry & Brain Health
Dr. Ghomi is a neuropsychiatrist with an engineering background focused on brain health and cognitive aging. His work bridges clinical neuroscience and digital health, with an emphasis on turning early, repeatable signals into practical monitoring and decision support over time.Quote:
"Earlier measurement improves the quality of downstream decisions."
Dr. Jon Overdevest, MD PhD
Otolaryngology & Sensory Neuroscience
Dr. Overdevest directs the Smell and Taste Center at Columbia University and is a dual-trained physician-scientist in otolaryngology and sensory neuroscience.
Dr. Yangyang Deng, PhD
Biostatistics & Longitudinal Health Modeling
Dr. Deng is a faculty biostatistician at Johns Hopkins University with deep expertise in longitudinal health modeling, wearable sensor data, and early disease detection.
Andrea Tales, PhD, FBPsS, FLSW
Neuropsychology & Dementia Research
Professor Tales holds a Personal Chair in Neuropsychology & Dementia Research at Swansea University, where she leads work on cognitive aging, attention, and everyday sensory/perceptual change in dementia.
"We’ve underestimated everyday sensory/perceptual change in dementia; aligning rigorous science with practical, scalable tools is the next step.”
Mariano Mastinu, PhD
Gustatory Assessment & Chemosensation
Dr. Mastinu is a researcher at the Smell & Taste Clinic, Department of Otolaryngology, Universitätsklinikum Carl Gustav Carus, TU Dresden. His work spans gustatory and trigeminal function and clinical strip-based taste assessment.
Dr. Molly Duong
Dr. Molly Duong, is a distinguished Optometrist based in Southern California.
Michael McKenna, AuD
Michael McKenna, AuD, areas of expertise and clinical interests include the diagnostic evaluation and management of hearing and vestibular disorders.